These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35773525)

  • 1. Herd immunity under individual variation and reinfection.
    Montalbán A; Corder RM; Gomes MGM
    J Math Biol; 2022 Jun; 85(1):2. PubMed ID: 35773525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.
    Gomes MGM; Ferreira MU; Corder RM; King JG; Souto-Maior C; Penha-Gonçalves C; Gonçalves G; Chikina M; Pegden W; Aguas R
    J Theor Biol; 2022 May; 540():111063. PubMed ID: 35189135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRS epidemics with individual heterogeneity of immunity waning.
    El Khalifi M; Britton T
    J Theor Biol; 2024 Jun; 587():111815. PubMed ID: 38614211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazil's COVID-19 Epicenter in Manaus: How Much of the Population Has Already Been Exposed and Are Vulnerable to SARS-CoV-2?
    Ferrante L; Duczmal LH; Steinmetz WA; Almeida ACL; Leão J; Vassão RC; Tupinambás U; Fearnside PM
    J Racial Ethn Health Disparities; 2022 Dec; 9(6):2098-2104. PubMed ID: 34590244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
    Tkachenko AV; Maslov S; Elbanna A; Wong GN; Weiner ZJ; Goldenfeld N
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33833080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of the concept of herd immunity, in the context of COVID-19 epidemic and the development of vaccines].
    Canals L M
    Rev Chilena Infectol; 2021 Aug; 38(4):495-499. PubMed ID: 34652394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on variable susceptibility, the herd-immunity threshold and modeling of infectious diseases.
    Carlsson M; Wittsten J; Söderberg-Nauclér C
    PLoS One; 2023; 18(2):e0279454. PubMed ID: 36791079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States.
    Mallela A; Neumann J; Miller EF; Chen Y; Posner RG; Lin YT; Hlavacek WS
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: individual and herd immunity.
    Bach JF; Berche P; Chatenoud L; Costagliola D; Valleron AJ
    C R Biol; 2021 Jun; 344(1):7-18. PubMed ID: 34213845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data.
    McMahon A; Robb NC
    JMIR Public Health Surveill; 2020 Nov; 6(4):e21168. PubMed ID: 33052872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of household structure on disease-induced herd immunity.
    Ball F; Critcher L; Neal P; Sirl D
    J Math Biol; 2023 Nov; 87(6):83. PubMed ID: 37938449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 reinfection - An enigmatic public health threat.
    Iyengar KP; Jain VK; Ish P
    Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33305559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending susceptible-infectious-recovered-susceptible epidemics to allow for gradual waning of immunity.
    El Khalifi M; Britton T
    J R Soc Interface; 2023 Sep; 20(206):20230042. PubMed ID: 37700711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital herd immunity and COVID-19.
    Bulchandani VB; Shivam S; Moudgalya S; Sondhi SL
    Phys Biol; 2021 Jun; 18(4):. PubMed ID: 33827059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemics with partial immunity to reinfection.
    Katriel G
    Math Biosci; 2010 Dec; 228(2):153-9. PubMed ID: 20875826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An SEIR Model with Time-Varying Coefficients for Analyzing the SARS-CoV-2 Epidemic.
    Girardi P; Gaetan C
    Risk Anal; 2023 Jan; 43(1):144-155. PubMed ID: 34799850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Incidence of SARS-CoV-2 Within Incarcerated Populations and Possible Implications for Herd Immunity.
    Xu J; Lim A; Rutherford G
    J Correct Health Care; 2022 Apr; 28(2):71-74. PubMed ID: 35143356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics.
    Marquioni VM; de Aguiar MAM
    PLoS One; 2021; 16(7):e0255438. PubMed ID: 34324605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.